PHI with autoimmune hepatitis (AIH)
How does this condition affect your private health insurance?
Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease where the body's immune system mistakenly attacks healthy liver cells. This leads to inflammation, which, if left untreated, can progress to scarring (fibrosis), cirrhosis, and ultimately liver failure. Symptoms are highly variable, ranging from mild fatigue and malaise to severe jaundice, abdominal pain, and dark urine. AIH is diagnosed through blood tests revealing elevated liver enzymes and specific autoantibodies, combined with a liver biopsy. Treatment primarily involves immunosuppressive medications, such as corticosteroids and azathioprine, to suppress the immune response and prevent further liver damage, often requiring lifelong management.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to months (before diagnosis and stabilization)
Duration of Illness (Lifetime)
Chronic, lifelong management required
Cost of Treatment (Initial)
High (initial diagnostics, hospitalization, medication)
Cost of Treatment (Lifetime)
Very High (lifelong medication, regular monitoring, potential for transplant)
Mortality Rate
Moderate to High (if untreated or uncontrolled; lower with effective treatment but complications can be fatal)
Risk of Secondary Damages
High (cirrhosis, liver failure, portal hypertension, hepatocellular carcinoma, side effects from immunosuppressants)
Probability of Full Recovery
Low (remission is achievable, but complete recovery without consequences is rare due to chronic nature)
Underlying Disease Risk
Moderate to High (association with other autoimmune diseases like celiac disease, thyroiditis, ulcerative colitis)